Renal Denervation: An Innovative New Treatment for High Blood Pressure
Approximately 30% of people worldwide have high blood pressure. Uncontrolled high blood pressure can cause serious heart complications. Dr. David Lee, interventional cardiologist at Stanford Medicine, runs clinical trials that use renal denervation to reduce blood pressure. Overactive signals between the heart, brain, and kidneys can raise blood pressure. Renal denervation is a minimally invasive procedure to remove nerves from the renal artery, which leads to the kidneys. Removing these nerves reduces the excess signals to lower blood pressure. Listen to Dr. Lee explain more about this leading-edge new treatment. Learn more: Resistant Hypertension: https://stanfordhealthcare.org/medical-conditions/blood-heart-circulation/resistant-hypertension.html Catheterization Angiography Laboratory https://stanfordhealthcare.org/medical-clinics/cath-lab.html David Lee, MD Interventional cardiologist Director of Cardiac Catheterization Laboratories Director of Interventional Cardiology Fellowship Program https://stanfordhealthcare.org/doctors/l/david-lee.html
Your Hypertension Care Team
Our multidisciplinary team brings together expertise from across seven specialties to better diagnose drug-resistant and severe hypertension. Our close collaboration means that you receive comprehensive, leading-edge care.
Extended Care Team